Nortech Systems (NSYS) AI Stock Analysis

Company Guidance

Management did not give formal forward-looking numeric guidance but emphasized converting a stronger backlog, reducing inventory and working capital to generate cash, and driving further margin expansion and operating leverage; they cited Q2 net sales of $33.5M (+9.3% YoY), gross profit $5.7M and gross margin of 17% (up 120 bps), Q2 operating income $623k (YTD operating income $670k vs. prior-year operating loss $871k), and Q2 net income $316k ($0.11 diluted) with YTD net income $282k ($0.09) vs. a $1.0M loss ($0.36) a year earlier. Backlog remained a key leading indicator: 90‑day shipment backlog was $33.4M (+6.3% sequential, +25.8% YoY) and total order backlog was $93.8M (+3.4% sequential, +19.8% YoY). Market trends cited included medical device sales +36% YoY, medical imaging +12.2%, industrial -4.7%, and aerospace & defense -12.8% in Q2 (but +8.7% YTD); incentive compensation expense was $402k (Q2) and $647k (YTD), $533k and $647k higher than 2025 comparatives. Liquidity and working capital metrics: cash and restricted cash $1.7M, revolving credit balance $7.6M with $3.6M unused availability, cash used in operating activities $2.4M YTD (vs. $2.8M prior), cash used by AR/contract assets $4.5M, cash used by inventory $3.5M and cash provided by AP changes $2.1M; management also noted record first-half gross margin and ample capacity across 4 Minnesota sites plus Monterrey and Suzhou to grow without significant CapEx.